Canopy Growth (TSE:WEED) |
C$18.73 |
£3,760m |
£3,000m |
First publicly-traded Canadian CBD company, and the first cannabis-producer to be listed on the NYSE in 2018. Multiple subsidiary companies and brands, including Tweed and Spectrum Therapeutics; with a product line the includes oils, concentrates, soft gel capsules and hemp. |
GW Pharmaceuticals (NMQ:GWPH) |
US$81.80 |
£2,060m |
£1,590m |
Global leader in developing cannabinoid-based medicines. Its Epidolex was the first FDA-approved medicine derived from cannabis plant, which it is focusing on turning into a block buster drug. |
Aurora Cannabis (TSE:ACB) |
C$1.13 |
£758m |
£988m |
Product line includes CBD oil, soft gels, and milled blends. Their CBD products are sold on a prescription, medical basis for Canadian markets. |
Tilray (NSQ:TLRY) |
US$5.54 |
£497m |
£780m |
First GMP-certified medical cannabis producer of cannabis flower and extract products; with its CBD products distributed to doctors, hospitals, governments, and researchers in five continents. |
Charlotte’s Web (TSE:CWEB) |
C$5.68 |
£344m |
£316m |
Charlotte’s Web has a unique formula to other CBD products, with a high amount of cannabidiol and low THC. Product lines includes CBD oil, gummies and capsules, as well as CBD dog products. |
Medical Marijuana (OTC:MJNA) |
US$0.015 |
£44m |
£50m |
Medical Marijuana developed the first legal supply of CBD and first publicly traded CBD company in the US. Has 8 brands of CBD products including CBD oils, hemp foods, clothing & baby products.
|
CV Sciences (OTC:CVSI) |
US$0.64 |
£52m |
£44m |
Focuses on pharmaceutical and consumer markets. Developing cannabidiol-based medicine pending FDA approval. Sells various botanical-based CBD consumer products in health food stores. |
Elixinol Global (ASX:EXL) |
A$0.275 |
£18m |
£10m |
Wholesale CBD supplier of products such as oil capsules, tinctures, liposomes, topicals, and hemp seeds. Sold through dispensaries, shops, health stores, and through healthcare professionals. |
Isodiol International (CBSX:ISOL) |
C$0.085 |
£2.8m |
£5.3m |
Isodiolis a manufacturer of natural, non-GMO, THC-free cannabinoid products. Products include mainstream CBD products such as capsules, oral sprays, topicals, and oils. Sells its products in bulk material, private label, and wholesale options |
Gaia Grow (CVE:GAIA) |
C$0.03 |
£3.4m |
£1.9m |
Committed to creating sustainable and clean products has an extensive product line of natural remedies and supplements including hemp extract oils. |